Author: courtneys

Automating Ultrasensitive Protein Biomarker Detection: SPEAR Immunoassays with the F.A.S.T.™ Liquid Handler

Nov 5, 2026Session 1: 10:00 AM CET Session 2: 1:00 PM ET Virtual SPEAR immunoassays detect protein biomarkers at attomolar levels from as low as 1 µL of diluted sample, a fraction of what other ultrasensitive platforms require. However, such sensitivity leaves little room for error during setup. Several steps are hard to do reproducibly […]

Read More

Meet Spear Bio at Biomarkers, CDx & Precision Medicine US 2026

September 23-24, 2026 San Diego, California Spear Bio is heading to San Diego for Biomarkers, CDx & Precision Medicine US 2026, bringing together leaders advancing biomarker discovery, companion diagnostics, clinical development, and precision medicine. Visit us at Booth 18 to connect with our team to discuss your protein biomarker program and learn how SPEAR technology […]

Read More

Exploring Tau Biology Through Blood-Based Biomarkers

Wednesday, September 30, 2026 Banner Health SPEAR BIO LUNCH & LEARN SPEAR BIO LUNCH & LEARN Exploring Tau Biology Through Blood-Based Biomarkers Banner Health | Lunch & Learn Date: Wednesday, September 30, 2026Time: 12:00 p.m. Location: Fluid Biomarker Conference Room, 3rd Floor Lunch: Complimentary lunch will be provided Explore Emerging Approaches to Alzheimer’s Biomarker Research Blood-based biomarkers are creating new […]

Read More

Expanding What’s Possible in Protein Biomarker Research

Monday, September 21, 2026 Biogen, Cambridge, MA SPEAR BIO LUNCH & LEARN SPEAR BIO LUNCH & LEARN Expanding What’s Possible in Protein Biomarker Research Biogen, Cambridge, MA | Lunch & Learn Date: Monday, September 21, 2026Time: 11:30 a.m.Location: Biogen, Cambridge, MA | Conference Room 821Host: Julie CzerkowiczLunch: Complimentary lunch will be provided. Explore New Approaches to Protein Biomarker Measurement Measuring […]

Read More

Exploring Tau Biology Through Blood-Based Biomarkers

Friday, September 11, 2026 University of Miami SPEAR BIO LUNCH & LEARN SPEAR BIO LUNCH & LEARN Exploring Tau Biology Through Blood-Based Biomarkers University of Miami | Lunch & Learn Date: Friday, September 11, 2026Time: 12:00 p.m. Location: Ryan Conference Room (1-21), Lois Pope Life Center | University of Miami Lunch: Complimentary lunch will be provided Explore Emerging Approaches to […]

Read More

Introducing SPEAR epTau 217 and eMTBR-Tau: Dissecting Alzheimer’s pathologies from early Tau phosphorylation to Tau tangles

Sep 9, 2026, 11:00 am ET Virtual The development of reliable blood-based biomarkers is transforming Alzheimer’s disease (AD) research, offering new opportunities to detect pathological changes earlier and monitor disease progression with greater precision.  In this SelectScience® webinar, held in partnership with Spear Bio, experts will introduce two novel blood-based biomarker assays designed to advance AD […]

Read More

Spear Bio’s SPEAR UltraDetect™ BD-pTau 217 Assay Named a 2026 R&D 100 Award Winner

Prestigious R&D 100 Award recognizes Spear Bio’s innovation in ultra-sensitive measurement of brain-derived pTau 217 in plasma WOBURN, Mass.–(BUSINESS WIRE)– Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, today announced that its SPEAR UltraDetect™ BD-pTau 217 Assay has received a 2026 R&D 100 Award. Presented annually by R&D World, the awards recognize 100 of […]

Read More

Spear Bio Expands Scope of ISO 13485:2016 Certification to Blood-Based Immunoassays

Expanded BSI Certification Recognizes Spear Bio’s Quality Management System for the Design, Development, Manufacture and Distribution of Blood-Based Immunoassays Spear Bio has announced that the scope of its ISO 13485:2016 certification has been expanded. Spear Bio’s Certificate of ISO Registration, issued by BSI Group, an independent certification body, recognizes the company’s Quality Management System as […]

Read More

Spear Bio to Unveil Novel Alzheimer’s Disease Immunoassays and Fully Automated Instrument Platform at AAIC 2026

Launches include the first commercially available singleplex eMTBR-Tau immunoassay, a novel pTau 217 assay for venous and capillary blood, and a fully automated instrument platform WOBURN, Mass.–(BUSINESS WIRE)–Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced plans to unveil new SPEAR immunoassay and instrument innovations at the Alzheimer’s Association International Conference® 2026, taking […]

Read More

Meet Spear Bio at AAIC 2026

Discover new SPEAR UltraDetect™ assay and instrument innovations for Alzheimer’s and neurodegenerative biomarker research Spear Bio is excited to exhibit at the Alzheimer’s Association International Conference® 2026 in London. Visit us at Booth 322 to learn how SPEAR immunoassays are advancing ultra-sensitive, low-volume biomarker measurement across Alzheimer’s disease, neurodegeneration, and preclinical research. At AAIC 2026, Spear Bio will introduce […]

Read More